NHS England Grants Palantir Expanded Access to Patient Data

NHS England has granted external contractors, including Palantir Technologies staff, wider access to identifiable patient data [1, 2].

The move heightens concerns regarding the privacy of sensitive medical records and the role of private corporations in managing public health infrastructure. Because the data is identifiable, critics argue the risk of privacy breaches increases as more third-party personnel gain entry to the system.

This access is part of the development of the NHS Federated Data Platform, a project with a cost of £330 million ^[1]. The platform aims to integrate data from across the health service to improve operational efficiency and patient care. However, the level of access granted to contractors has become a point of contention.

Reports on the scope of this access vary between sources. Some descriptions characterize the access as wider entry to sensitive patient data ^[2], while other accounts describe it as unlimited access to identifiable patient information ^[1].

Palantir, a U.S.-based data analytics firm, is a primary contractor for the platform. The partnership has faced backlash from privacy advocates who question the security protocols in place when external staff handle identifiable records. The controversy centers on whether the benefit of a centralized data platform outweighs the potential risk to individual patient confidentiality.

NHS England has not detailed the specific safeguards implemented for this expanded access, but the project continues to move forward despite the growing criticism from public health observers ^[2].